Therapy-related B-cell acute lymphoblastic leukemia after treatment for multiple myeloma
{{output}}
Changing landscape of treatment has significantly improved survival in multiple myeloma (MM) in last two decades by using proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs), monoclonal antibodies, and autologous stem cell transplantation (ASCT). With ... ...
